Health
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer – PRNewswire
/PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI)…
SILVER SPRING, Md., April 9, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
“Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with…
Continue Reading
